These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2389439)

  • 1. Are serum creatinine levels adequate to identify the onset of chronic cyclosporine A nephrotoxicity?
    Mobb GE; Veitch PS; Bell PR
    Transplant Proc; 1990 Aug; 22(4):1708-10. PubMed ID: 2389439
    [No Abstract]   [Full Text] [Related]  

  • 2. Is chronic nephrotoxicity of cyclosporine avoided by the triple drug regimen?
    Hiesse C; Gardin JP; Lantz O; Cantarovich M; Bensadoun H; Benoit G; Bellamy J; Paillard M; Charpentier B; Fries D
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1534-6. PubMed ID: 2652495
    [No Abstract]   [Full Text] [Related]  

  • 3. Verapamil prevents posttransplant delayed function and cyclosporine A nephrotoxicity.
    Dawidson I; Rooth P; Alway C; Dulzo T; Palmer B; Lu C; Peters P; Sagalowsky A; Sandor Z
    Transplant Proc; 1990 Aug; 22(4):1379-80. PubMed ID: 2202113
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcium channel blockers and early cyclosporine nephrotoxicity after renal transplantation: a prospective randomized study.
    Morales JM; Andrés A; Alvarez C; Prieto C; Ortuño B; Ortuño T; Paternina ER; Hernandez Poblete G; Praga M; Ruilope LM
    Transplant Proc; 1990 Aug; 22(4):1733-5. PubMed ID: 2389446
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic cyclosporine-associated nephrotoxicity.
    Porter GA; Bennett WM
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):204-9. PubMed ID: 3515689
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine-induced nephrotoxicity: role of prostaglandins.
    Jorkasky D; Audet P; Williams S; Grossman R; Conrad M
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1742-4. PubMed ID: 3079035
    [No Abstract]   [Full Text] [Related]  

  • 7. Fractional excretion of sodium is an early predictor of cyclosporine nephrotoxicity after renal transplantation.
    Morales JM; Andrés A; Hernández E; Prieto C; Ortuño T; Montoyo C; Moreno F; Rodriguez-Paternina E; Farías J; Rodicio JL
    Transplant Proc; 1990 Aug; 22(4):1728-9. PubMed ID: 2389444
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of acute tubular necrosis on cyclosporine-treated kidney transplants.
    Paramasivan ON; Griffin PJ; Ross WB; Salaman JR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2085. PubMed ID: 3274474
    [No Abstract]   [Full Text] [Related]  

  • 9. Is serum creatinine a reliable expression of an adequate cyclosporine immunosuppression?
    Cantarovich F; Cantarovich D; Suso E; Lefrançois N; Touraine JL; Traeger J
    Clin Nephrol; 1988 Jan; 29(1):9-11. PubMed ID: 3289807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term nephrotoxicity in liver transplantation.
    Poplawski S; Gonwa T; Goldstein R; Husberg B; Klintmalm G
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2469-71. PubMed ID: 2652809
    [No Abstract]   [Full Text] [Related]  

  • 11. Improvement of renal function after conversion from cyclosporine only to prednisolone-azathioprine followed by late-onset graft failure in renal transplant patients.
    Tegzess AM; van Son WJ; Beelen JM; Sluiter WJ; Meijer S; Slooff MJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2000-4. PubMed ID: 3547904
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporine nephrotoxicity in orthotopic liver transplantation.
    Gonwa TA; Poplawski SC; Husberg BS; Nery JR; Klintmalm GB
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):401-4. PubMed ID: 3291276
    [No Abstract]   [Full Text] [Related]  

  • 13. Nephrotoxicity of cyclosporine in autoimmune diseases.
    Hannedouche TP; Delgado AG; Gnionsahe AD; Boitard C; Noël LH; Grünfeld JP
    Adv Nephrol Necker Hosp; 1990; 19():169-85. PubMed ID: 2105578
    [No Abstract]   [Full Text] [Related]  

  • 14. Possibility of recognizing immunologic and cyclosporine A damage by urinary neopterin excretion in kidney transplant recipients.
    Magalini SC; Nanni G; Sambo A; Agnes S; Luciani G; Pozzetto A; Avolio A; Cittadini A; Castagneto M
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1686-8. PubMed ID: 3274405
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of donor age and sex on cyclosporine associated nephrotoxicity.
    Iguro T; Okazaki H; Sato T; Jimbo M; Oguma S
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1554-5. PubMed ID: 2652504
    [No Abstract]   [Full Text] [Related]  

  • 16. Functional and histopathological cyclosporine A nephrotoxicity in children after organ transplantation.
    Laine J; Jalanko H; Krogerus L; Fyhrquist F; Rönnholm K; Leijala M; Höckerstedt K; Holmberg C
    Transplant Proc; 1995 Feb; 27(1):1131-3. PubMed ID: 7878823
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclosporine-induced chronic nephropathy in human recipients of cardiac allografts.
    Moran M; Tomlanovich S; Myers BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):185-90. PubMed ID: 3895659
    [No Abstract]   [Full Text] [Related]  

  • 18. Measurement of true glomerular filtration rate in renal transplant patients receiving cyclosporine.
    Wilkinson A; Ross EA; Hawkins R; Danovitch G
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1739-41. PubMed ID: 3079034
    [No Abstract]   [Full Text] [Related]  

  • 19. Morphological and functional findings in renal transplant recipients on cyclosporine and azathioprine treatment.
    Backman U; Bohman SO; Johansson G; Lindgren PG; Wahlberg J
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1639-40. PubMed ID: 3079029
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine-associated nephrotoxicity is not intractable.
    Loertscher R
    Transplant Proc; 1987 Aug; 19(4):3486-9. PubMed ID: 3303520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.